Literature DB >> 20809132

Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor.

Daniela Gallerano1, Siva Charan Devanaboyina, Ines Swoboda, Birgit Linhart, Irene Mittermann, Walter Keller, Rudolf Valenta.   

Abstract

HIV-1 virus infectivity factor (Vif) is one of the four accessory proteins that are characteristic of primate lentiviruses and critically required for the infection of host cells. Vif plays a key role in replication and transmission of the virus in non-permissive cells, such as primary T cells and macrophages. Using co-precipitation and co-fractionation techniques, evidence has been provided that Vif interacts with a variety of host proteins, such as the cytidine deaminases APOBEC3G and 3F, the Cullin5/EloBC ubiquitin-ligase complex, Fyn and Hck tyrosine kinases, as well as with viral components, such as the immature Gag precursor and viral RNA. We report on the expression, purification and molecular characterization of a folded recombinant subtype C Vif. Vif was expressed in E. coli with a C-terminal hexahistidine tag and purified by nickel affinity chromatography. We obtained approximately 5 mg protein per liter of bacterial culture, with a purity >95%. The expected molecular mass of 23.7 kDa was confirmed by mass spectrometry. Although dynamic light scattering and small angle X-ray scattering measurements revealed the presence of high molecular weight aggregates in the protein preparation, circular dichroism analysis showed that the protein contains mainly folded β-sheet elements and exhibits remarkable thermal stability (T (m) > 95°C). Recombinant Vif may be used as a tool to study its biological functions and tertiary structure, as well as for the development of diagnostic, therapeutic and preventive strategies for HIV-1 infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809132     DOI: 10.1007/s00726-010-0725-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  9 in total

Review 1.  Structural insights for HIV-1 therapeutic strategies targeting Vif.

Authors:  Jason D Salter; Guillermo A Morales; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2014-08-12       Impact factor: 13.807

2.  Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.

Authors:  Dona Sleiman; Serena Bernacchi; Santiago Xavier Guerrero; Franck Brachet; Valéry Larue; Jean-Christophe Paillart; Carine Tisne
Journal:  RNA Biol       Date:  2014-07-22       Impact factor: 4.652

3.  On the solution conformation and dynamics of the HIV-1 viral infectivity factor.

Authors:  Sean R Marcsisin; Purushottam S Narute; Lori A Emert-Sedlak; Marek Kloczewiak; Thomas E Smithgall; John R Engen
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

4.  Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.

Authors:  Katarzyna Niespodziana; Clarissa R Cabauatan; Petra Pazderova; Phyllis C Vacal; Judith Wortmann; Walter Keller; Peter Errhalt; Rudolf Valenta
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

5.  Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.

Authors:  Xiaohong Zhou; Sean L Evans; Xue Han; Yayan Liu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

6.  Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.

Authors:  Daniela Gallerano; Portia Ndlovu; Ian Makupe; Margarete Focke-Tejkl; Kerstin Fauland; Eva Wollmann; Elisabeth Puchhammer-Stöckl; Walter Keller; Elopy Sibanda; Rudolf Valenta
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  ELISA-Based Assay for Studying Major and Minor Group Rhinovirus-Receptor Interactions.

Authors:  Petra Pazderova; Eva E Waltl; Verena Niederberger-Leppin; Sabine Flicker; Rudolf Valenta; Katarzyna Niespodziana
Journal:  Vaccines (Basel)       Date:  2020-06-18

8.  Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response.

Authors:  Kristina Borochova; Katarzyna Niespodziana; Margarete Focke-Tejkl; Gerhard Hofer; Walter Keller; Rudolf Valenta
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

9.  Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.

Authors:  Karen K Siu; Azmiri Sultana; Farshad C Azimi; Jeffrey E Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.